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human medicine, as well as being widely applied in the scope of
veterinarymedicine for over 50 years. The compounds of ketamine,
known as arylcyclohexylamines, comprises a number of substances
with psychoactive effects, some of which are used as pharmaceuti-
cals, while some are misused resulting in acute intoxications pre-
senting in a physical and psychological way, with organ damage
including brain, liver, and urinary tract of long-term users. The sig-
niﬁcant adverse effects within the urinary tract, including kidneys
and bladder, have been recently recognized in more than one-
third of long-term ketamine users. The severity appears to be corre-
lated to the amount, the duration, and the frequency of usage.1e3
Most of ketamine pharmacodynamics have been investigated of
the neurotransmission effects, act as noncompetitive antagonists
at N-methyl-D-aspartate receptors where they bind at the so-
called phenicyclidine site on the N-methyl-D-aspartate receptor,
and are believed to be the principal targets for the anesthetic action
and psychotomimetic properties.4,5 The analgesic action of keta-
mine also attributes to the inhibition of nitric oxide synthase result-
ing in a decrease in nitric oxide production, blockade of voltage-
sensitive calcium channels, sodium channel depression, and inhibi-
tion of monoamine reuptake, as well as possesses anticholinergic
activity and antagonist activity at muscarinic acetylcholine recep-
tors.6,7 However, the mechanism of ketamine cystitis is still not
clear. Histopathology shows the urothelial ulceration with eosino-
philic inﬁltration within lamina propria with urothelial atypia alike
to carcinoma in situ, yet negative of CK20.8,9 Baker et al. demon-
strated that which derived from a debilitating pathology, with a
combination of a compromised urinary barrier and widespread
nerve hyperplasia within the bladder wall, including the develop-
ment of a novel neuroma with similarities to Morton's neuroma,
with increased expression of nerve growth factor receptor.10
Several therapies have been attempted for the management of ke-
tamine cystitis, including detoxicationwith various pharmaceutical
agents, nonsteroid anti-inﬂammatory agents, and intravesical
treatments; however, the results are either limited or less success-
ful. Nonetheless, augmentation cystoplasty has been applied in pa-
tients with severely contracted bladders.
South-East Asia appears to be the most common area for the
prevalence of ketamine misuse; with ketamine being reported as
the second-most popular drug of abuse followed by methamphet-
amine in Taiwan.11 The authors should be encouraged to attempt to
treat ketamine cystitis with intravesical hyaluronic acid instillation.
However, the nuances of histological and molecular changes before
and after treatment are crucially important to verify the therapeu-
tic effect. Moreover, nearly 50% of ketamine users were poly-drugshttp://dx.doi.org/10.1016/j.urols.2015.08.008
1879-5226/Copyright © 2015, Taiwan Urological Association. Published by Elsevier Ta
creativecommons.org/licenses/by-nc-nd/4.0/).users or adulterated with other substances including cocaine,
mephedrone, benzocaine, paracetamol, methoxetamine, and
amphetamine; hence, the vulnerability of ketamine cystitis from
different drugs interaction needs to be investigated.12 Furthermore,
ketamine addiction is considered as dependent forming for most
abusers and associated with a high relapse rate after abstinence;
therefore, a successful treatment for ketamine addiction, including
related cystitis, needs to be coordinated with physical and psycho-
social interventions.
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